coccus; skin lesions often very directly followed contamination of the fingers from the mouth.* In a six-year period, [1938] [1939] [1940] [1941] [1942] [1943] inclusive,t 203 patients with eczema were treated in the pediatric out-patient service of the New Haven Hospital, eczema accounting for approximately one per cent of the total admissions. Sixty-four of these 203 (about 30 per cent) presented clinical evidence of infection at some time during the period of observation. The total number of infections was 103 since some patients became infected several times. One child was infected eight times over a five-year period; on at least two occasions, infection was by hemolytic streptococci as demonstrated by cultures from the lesions. Children treated in the out-patient service are not included in the general discussion which follows in this paper unless they were admitted to the hospital wards. Dispensary patients were not followed regularly and carefully enough to be of value in this study. However, the skin was cultured in 39 instances of infection and hemolytic streptococci were recovered from 26 (66 per cent). From this small series, it would appear that hemolytic streptococci are associated with infected eczema in about two-thirds of the cases; it is of interest that these organisms were recovered from 17 of 21 patients hospitalized from the dispensary (81 per cent); such hospitalization was without knowledge of the skin cultures at the time. In general, it may be said that the child requiring hospitalization for the treatment of eczema is likely to be under three years of age and the skin lesions are usually infected with hemolytic streptococci; * Recently, cultures were taken from the fingers of 60 infants and children who were under treatment in the dispensary and wards of the New Haven Hospital for a variety of illnesses. Hemolytic streptococci were recovered from 6 and pneumococci from 2. Staphylococci were present on the fingers in varying numbers in all cultures. The frequency with which hemolytic streptococci were demonstrated may be misleading unless the presenting illnesses of these patients are considered. Five had clinical streptococcal infection of the upper respiratory tract including one case of scarlet fever. The presenting illness of the sixth child was "impetigo" of the face. He had a recent sore throat with fever. All children had hemolytic streptococci in cultures of the fingers and rhinopharynx and these organisms belong in Group A. In the case of the sixth child the organisms were also recovered from the skin lesion. For each patient streptococci from all sources were identical as to serological type.
t The three post-sulfonamide years of the study summarized in Table 1 plus the   next three years are the ones under consideration here. some admissions for eczema, of course, are dictated by social rather than medical requirements.
In Table 2 is shown the incidence of eczema cases on the inpatient Pediatric Service of the New Haven Hospital for six years, 1938-1943 inclusive; there were 76 such admissions. The present study is based on data available in the records of these patients and is admittedly very inadequate because the prime importance of infection in eczema in children has been appreciated only gradually and a careful investigation of the subject was never really planned. Therefore, this report must be regarded as an orientation procedure, designed to call attention to a condition that is recognized but is not adequately stressed, and to stimulate a carefully planned investigation of the subject. A list of patients was prepared showing their age at the time of each of the 76 admissions. The tabulation revealed in our series the well-known fact that atopic dermatitis is most frequently seen in children under two years of age (64 per cent, this series). There was a fair number of cases during the next three years of life but during the ensuing years the incidence of eczema admissions became low. The age period when eczema is most common is the same as that when the childhood type of streptococcal fever is most frequently seen.
Another listing of cases setting forth the admissions for eczema by months showed that the patients entered the hospital in each month of the year but the greatest number was in the spring months; there is a parallelism here between eczema admissions and those for streptococcal disease. 2 A diagnosis of infected eczema was made in the first instance on many of the cases in this series on clinical grounds. The diagnosis was not always supported by data from cultures. Staphylococci are often cultured from normal skin and when present in cases of eczema their rOle is difficult to appraise beyond observation as to their presence in abscesses or in the blood; there were no such occurrences in this series. Bacteriological study of the staphylococci isolated from cases of clinically infected eczema generally included their ability to ferment mannite and coagulate plasma-tests for pathogenicity. These tests were usually performed when staphylococci alone were present in cultures of the skin; when hemolytic streptococci were simultaneously recovered, the staphylococci were often simply identified by colony-appearance and stained smear. Hemolytic streptococci in most instances out-numbered the staphylococci. This is another reason why we place greater emphasis on the hemolytic streptococcus as the primary offending organism.
Concerning the incidence of hemolytic streptococci in general, it is germane to recall, that Colebrook, Maxted, and Johns cultivated organisms belonging to Group A from the "hands of 7 out of, 181 normal individuals (3.8 per cent)."5 However, it would seem that this bacterium is rarely present in individuals not suffering from or recently convalescent from some form of streptococcal fever; this seems to be true so far as infants and young children are concerned. In the study upon which Table 1 is based, it was demonstrated that in our hospital cases of the period, 15 per cent of the patients had active streptococcosis and 10 per cent were carriers of hemolytic streptococci in the rhinopharynx even when active streptococcosis was not diagnosed. Boisvert"3 found a carrier rate of 7 per cent for Group A hemolytic streptococci; the subjects from whom rhinopharyngeal cultures were taken were 190 members of 30 families in each of which at least one member had pertussis.
In our series of eczema patients, 48 of the 76 (re-admissions considered as new patients), showed clinical evidence of infection as well as of eczema of the skin (Table 3 ). There is no record of skin cultures on three of these patients but some of the bacteriological data concerning the 45 patients whose skin was cultured are shown in Table 3 . Hemolytic streptococci were demonstrated in 36 cases (80 per cent) and they were the only organisms demonstrated in cultures from 7 patients (15 per cent); staphylococci were the only organisms demonstrated in 9 patients (20 per cent). In four Of the 36 patients whose skin cultures showed hemolytic streptococci, 28 (77 per cent) also carried that organism in the rhino-pharynx as demonstrated in cultures. In 12 patients whose skin was either not cultured (3) or the cultures showed no hemolytic streptococci (9) , this organism was found in cultures from the upper respiratory tract in four (33 per cent) and, also, in the blood of one of these. Thus, taking all of the cases of clinically infected eczema (48) into consideration, whether or not hemolytic streptococci were demonstrated on the skin, that parasite was found in the upper respiratory tract of 32 (66 per cent of the total); by contrast, the hemolytic streptococcus was demonstrated in the rhinopharynx of only five (17 per cent) of the 28 patients whose eczema was not clinically infected. Most regrettably, no cultures of the skin of 16 of these 28 patients were taken. This suggests that hemolytic streptococci may well have been present on the skin in a fair percentage of the twelve infected cases in whom cultures either were not taken or showed only staphylococci.
Blood cultures were positive for hemolytic streptococci* in three of the 36 infants with clinically infected eczema and having skin cultures positive for that organism; there were four positive cultures from these three patients. In a fourth infant, whose eczema was obviously infected, cultures of the nose, throat, aural discharges, and blood were positive for hemolytic streptococci, but skin cultures were not taken. All patients having positive blood cultures were infants (ages 6 mos., 8 mos., 1X2 years, and 2 years, respectively).
In Table 4 are shown such data as are available in this series concerning the Lancefield groups of hemolytic streptococci8' 10, 14 from cultures of patients with eczema. The data are indeed meager; Group A organisms, the usual human pathogens, were cultivated from the skin in only 13 patients; in 20 cases in which no grouping was carried out Group A may or may not have been well represented. In the proved Group A and C cases, the parallelism between rhinopharyngeal and skin cultures is close. In seven instances the serological types of the Group A strains were determined. For each patient, organisms from the rhinopharynx and skin were identical as to type. This suggests that eczema in a child who has streptococcal fever or who is a carrier of hemolytic streptococci is likely to become infected. This relationship also holds for other skin conditions in children. Higgins,7 in a thesis prepared in this Clinic,
showed that of 71 cases of skin diseases (impetigo, eczema, postauricular intertrigo, epidermophytoses, vaccinia, etc.) 62 showed hemolytic streptococci, Group A, in skin cultures and of these 20 per cent were proven to have that organism in the upper respiratory tract; there was one Group C hemolytic streptococcus invader in Higgins' series. Cultures of the nose, throat, and skin lesions yielded hemolytic streptococci. The organisms from both the rhinopharynx and skin were identified as of a Group A, type 11 strain (one of the serological types prevalent in New Haven at the time). Admission blood culture was sterile.
The baby was restrained, placed on cellophane, and sedated with phenobarbital to relieve the itching. Diet consisted of goat's milk with added vitamins. Five per cent sulfathiazole ointment in white vaseline was applied to the skin lesions every four hours for seven days. The temperature fell to normal limits on the sixth hospital day. The skin lesions improved and the adenopathy decreased, but a large furuncle on the scalp persisted. A repeat skin culture on the tenth hospital day was negative for hemolytic streptococci. Sulfathiazole ointment was replaced by a crude coal tar ointment with continued improvement in the eczema. Sulfathiazole was administered by mouth and the furuncle subsided without suppuration. The baby was discharged on the twenty-eighth hospital day to be followed in the pediatric allergy clinic. Table 4 shows that there were four cases in the present series in which the organism isolated from the skin was a Group C hemolytic streptococcus.8 10,14 One of these patients-an infant of eight months-was gravely ill; not only was there extensive eczema which appeared infected but also on face and neck there was a "pox-like" lesion (previously referred to) from which Dr. Wenner18 isolated a herpes simplex-like virus; the patient was hospitalized for 38 days. A second infant in this category, a boy aged 4 months, was gravely ill with pharyngitis, adenitis, and extensive weeping eczema. The fever showed frequent spikes to 390 C. or 400 C. and there was a leukocytosis of 29,300 and an eosinophilia of 15 per cent. The patient was hospitalized 53 days; the skin was clear on discharge. The third Group C patient, also an infant, had a simple mastoidectomy at which cultures were not taken; the fourth case was that of a 15-year-old girl whose scalp and ears were a mass of weeping, excoriated, and crusted areas superimposed on a chronic eczematous base. Group C organisms are usually not regarded as important human pathogens; this is not invariably the case. It would appear to us that they were acting as pathogens in these four patients.
The patient from whom a Group G hemolytic streptococcus was isolated from the skin was a girl of 16 months. The eczema was dry, most marked in the antecubital and popliteal spaces and on the wrists. There was a degree (centigrade) of fever for one week of a three-week period of hospitalization. The white blood count was 22,000; eosinophiles 5 per cent. Group G hemolytic streptococci are not considered to be human pathogens, although rare exceptions have been reported. In this instance, their rOle as pathogens is indeed debatable. The low-grade fever and leukocytosis suggest infection but the appearance of the skin belied the presence of infected eczema.
The treatment of children with eczema in this clinic is that generally carried out elsewhere. For small children, restraint to prevent scratching is practiced and sedatives may be employed to the same purpose; when there is moisture, exposure to heat under an electric light cradle is regarded with favor; ointments prescribed usually contain some coal tar derivative; foods have been mixtures based on dried half-skimmed cow's milk, goat's milk, or soy-bean or partially digested casein prepared foods-all with vitamin supplements, in purified form as far as possible. In older children, attempt is made to determine possible allergens and to control environment accordingly.
As it became clear that many cases of eczema were also cases of streptococcal disease and that the skin was frequently contaminated with hemolytic streptococci, the use of sulfonamides orally and externally in soaks and ointments in treatment was tried. Only ten of the 48 patients with infected eczema in this series did not receive sulfonamide therapy and 38 were so treated by one method or another regardless of bacterial etiology. Table 5 refers only to 34 hemolytic streptococcal infected eczema cases of which 26 received sulfonamide therapy. Methodology was experimental; various sulfonamides were tried orally and externally and in combination. Applications to the skin varied as to base for administration, as to concentration, and as to the special sulfonamide to be selected.
Data concerning sulfonamide treatment of 34 patients whose eczema was infected with hemolytic streptococci are shown in Table 5 . Twelve patients (B) were treated orally and externally; five (C) orally only; and nine (D) externally only. Eight patients (A) were not treated with sulfonamides.
Since our interest in infection of the skin of eczematous children stemmed directly from studies on streptococcosis,2 early experiments in treatment began with the exhibition of sulfonamides both locally and orally for streptococcal skin diseases. So far as infected eczema administration of sulfonamides is indicated. However, the usual form of streptococcal disease associated with infected eczema is that which we have called "streptococcal fever"-pharyngitis, cervical adenopathy, and fever lasting usually for six weeks;2 it is a malady influenced by sulfonamides in a very disappointing measure. In these cases, constituting the great majority of our series, we have come to rely on the local application of an ointment of five per cent sulfathiazole in white vaseline;9 11 15 the lesions are kept greased; no definite number of applications is prescribed. The value of this treatment rests on clinical appraisal of the total situation. Our good results in the dispensary patients (to whom no sulfonamides were administered orally) and our eventual appreciation that sulfonamides were of doubtful value in treating streptococcal fever led us to the belief that our favorable results were due largely to local applications. Under this regime, the value of the sulfonamides is indicated by general systemic improvement, by lowering the fever, by a clearing of exudation and crusting, and by eventual reduction in adenopathy. The children treated solely by local applications of sulfonamides remained in the hospital for a shorter period than did those treated orally with and without ointment, but their course in respect to time was conditioned by other circumstances, such as the presence or absence of the more serious complications referred to in the previous paragraph. At any rate, any appreciable reduction in hospitalization as a rule would not seem likely, for the infection is engrafted upon a chronic dermatitis. Once in an institution, the child is kept on for treatment of the latter malady although the strictly streptococcal aspect may have shown amelioration; the line of demarcation between the two is usually not clear. The physician is treating two diseases etiologically different but clinically fused; healing of the infection is ameliorative but not curative of the eczema. And, further, the infection although not chronic, tends to recur because it is usually a part of streptococcal fever, a sub-chroni'c ailment. Table 5 does not furnish adequate data for a discussion of sulfonamide blood concentrations in our series. One reason for the paucity of our observations is found in one's hesitation to draw blood when inflammation of the skin over the whole body exists. All levels obtained were under four milligrams per cent with the exception of two cases mentioned in the footnote to Table 5 , in which the highest readings were 7.3 and 16.7 mg. per cent, respectively. We used sulfanilamide, sulfapyridine, sulfathiazole, and sulfadiazine in onehalf to ten per cent concentrations in ointments and soaks; as stated, the application most frequently used was five per cent sulfathiazole ointment; it might be wise to use a two per cent ointment in very extensive lesions in which there is much broken skin. On this point, Cole4 comments thus:
Apparently in using sulfonamide compounds on the skin the amount of absorption, if any, will depend on its concentration in the medicament, on the condition of the skin, intact or broken, on the drug itself (thus sulfathiazole is absorbed less than sulfanilamide) and on the type of base. If one is working with sulfonamides in glycerin there will be far more absorption than from an ointment base or even from an oil in water base. Apparently, however, in practically no case in which sulfathiazole has been used will there be appreciable absorption into the blood stream.
Our favorable regard for a five per cent sulfathiazole ointment having petrolatum alba for its base raises the question of a greasy medicament. We have no data upon which to enter a debateonly the fact that in most cases this ointment seemed to give very satisfactory results. 16 In his review on chemotherapy in dermatology, Cole4 states that greasy bases are unsatisfactory for applying sulfonamides locally. A grease will seal off the area, it does not mix with serum, and it may coat over the underlying infection and furnish an anaerobic pocket in which infection may thrive. Moreover, bacteria covered -with a film of grease will not be so easily reached by the medicament. Oil in water emulsion bases provide a more satisfactory medium than vanishing cream compounds and are apparently the best bases for applying any of the sulfonamides.
We cannot state to what degree eczematous skin as a carrier of hemolytic streptococci was influenced by sulfonamide ointments; our data establish only the fact of clinical improvement and that in many cases cultures became negative before the patient was discharged. We know that re-infections seem to have taken place in certain patients.
Our data on infection of the skin with hemolytic streptococci of Group C are too meager to merit conclusions as to the influence of sulfonamide treatment.
The question of sensitization reactions3' 6, 12, 17 to sulfonamides is one of great importance in the subject presented here. If, for example, a relatively benign post-auricular intertrigo infected with hemolytic streptococci is cured with topical application of five per cent sulfathiazole ointment only to have the patient become hypersensitive so that the drug cannot be given on a subsequent occasion when he may be seriously ill with meningitis, then the price for the original success is much too high. We quote Cole4 again as follows:
In the light of present data sulfonamides should not be administered locally for more than five days because of the danger of sensitizing the individual and perhaps later precluding internal sulfonamide therapy where the situation may involve a far graver disease, e.g. a pneumonia or a bacteremia.
In our series, certainly the average period over which the drug was administered was nearer ten than five days; although two patients developed fever as a toxic effect of the drug, no case of sensitization in the sense of a re-administration phenomenon occurred. Four patients received sulfonamides during two hospital admissions and a fifth child on four separate occasions without toxic reaction. Eight of the twelve admissions were for infected eczema, two for pneumococcal pneumonia, and two for extensive burns which were infected. One must recall that a vast number of persons have received sulfonamides for very minor illnesses. Infants because of their youth are perhaps somewhat less likely to have received sulfonamides, particularly in repeated courses. For this reason-and probably others-patients with infantile eczema may not show the sensitization phenomenon so readily as older children and adults. Lyons and Balberor state that 36 per cent of their patients (adults) experienced febrile reactions when sulfathiazole was administered although such reactions occurred in only five per cent of their cases in which a single course of the drug was given. Green, Steckel and Michener were unable to confirm these observations. In our opinion, the physician will have to make the decision in any given case of eczema infected with hemolytic streptococci as to whether almost certain improvement with sulfonamide ointment should be achieved at the risk of possible toxic or sensitization effects.
Sulfonamide treatment of infantile eczema infected with hemolytic streptococci may be superseded by other medicaments such as penicillin. Reports on very limited observations indicate favorable developments in penicillin therapy in this field.
In the two exceptional cases of combined streptococcal and viral infection of eczema (footnote to Table 5 ) the use of sulfathiazole ointment seemed definitely harmful with respect to the herpetic lesions; they spread and became confluent and indurated.
Summnary and conclusions
From a survey of the material presented in this paper it is obvious that any consideration of infantile eczema must take into account the likelihood that, in a large number of the severe cases, the skin lesions areinfedted with hemolytic streptococci; the statement is true for New Haven and probably also for other communities where streptococcosis is common.
Furthermore, the course of the patient's illness is significantly altered by the streptococcal infection-there is more fever, prostration, irritability, local exudation, and adenopathy than in uncomplicated eczema; bacteremia may be present in a not inconsiderable number of patients.
Certain other facts deserve emphasis. 1. Atopic dermatitis -and streptococcal fever-rhinopharyngitis, cervical adenitis, low-grade fever of several weeks' duration-are common diseases in the same period of life, the first three years.
2. When a child has eczema and streptococcal fever concomitantly, it is possible and likely that the skin lesions will become endogenously infected with hemolytic streptococci. In some cases the skin may become infected exogenously and perhaps the upper respiratory tract may be contaminated from the skin; it is probably not possible to determine in most of the cases the sequence of events; but the important fact is clear-that infection of the upper respiratory tract and infection of eczematous skin in children are often present at the same time.
3. Treatment of the skin lesions with an ointment of five per cent sulfathiazole in white vaseline is an effective medicament. Oral administration of a sulfonamide is not indicated in simple streptococcal fever with simple infection of the eczematous lesions. However, a sulfonamide should be given orally if there is bacteremia, erysipelas, progressing adenopathy, or internal streptococcal localization.
4. The sulfonamide treatment of infected eczema is in addition to and not in lieu of the usual procedures carried out in cases of atopic dermatitis; control of infection does not cure eczema but does markedly facilitate its care and promote a favorable course.
5. In this series of 48 cases of infected eczema (38 treated with sulfonamides) febrile reactions to the drugs were occasionally observed but no incidents of sensitivity to re-administration were recognized. Our experience in this respect may be favorably conditioned by the fact that our patients are, for the most part, young children.
6. In this series, ointment was applied in the average case for a week or ten days; endogenous re-infection is possibly occurring often; we were unable to detect any harmful effects of too prolonged exhibition of sulfonamides. 7 . The physician will have to decide in the individual case whether or not the danger of inducing a sulfonamide sensitivity and thus prohibiting subsequent use of the drug seems greater than the benefit derived from treatment of the condition at hand. Fear of developing sensitivity probably rules out prophylactic use of ointment in cases of uninfected eczema in patients with streptococcal fever.
